Research & Development
Top Medicine exclusively focuses on fine pharmaceutical chemistry and high-tech products development which are brewed up in its provincial-level R + D Center and its new state-of-the-art multi-functional pilot plant. In collaboration with a R + D Center in Shanghai, Top Medicine keeps aligned with new products development programs through laboratory, pilot and commercial operations. It has also established very close relationship with Shanghai Institute of Animal Parasitology (SIAP), Chinese Academy of Agricultural Sciences (CAAS), Sichuan Institute of Antibiotics, Institute of Microbiology, and Shanghai Fudan University which all are technical backbones and driving forces to its economic takeoff and growth.
Top Medicine upholds the strategy of developing technology-intensive APIs and pharmaceutical intermediates in the following 3 to 5 years which will lay a solid foundation for being listing on stock market and rapid development.

Development Potentials
With a total area of 60,000 sq. meters, it has adequate space for further development except for 18,000 sq. meters dedicated to existing production.
It has a total staff of 300 people including 64 technicians, 25 laboratory analysts and directors, and 10 QA officers.
The company boasts a provincial-level R+D center and a state-of-the-art pilot plant which work as technical platforms for new products development.
A dedicated API workshop designed and built in accordance with cGMP requirements shows impetus for economic growth. Modern warehousing facilities are available to guarantee prompt delivery of goods.
The practice of cGMP is implemented and followed throughout production activities and quality management.